(Q43832508)

reason for preferred rank

27 November 2017

title

Ductal carcinomain situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy (English)

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

8 December 2022

Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848153

8 December 2022

1 reference

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

8 December 2022

author name string

D. Rosner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848153

8 December 2022

W. W. Lane

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848153

8 December 2022

R. Penetrante

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848153

8 December 2022

language of work or name

English

0 references

publication date

1 March 1991

1 reference

27 November 2017

15 March 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1848153

full work available at URL

8 December 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

8 December 2022

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

8 December 2022

1 reference

27 November 2017

volume

67

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

1498-1503

1 reference

The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819910315%2967%3A6%3C1498%3A%3AAID-CNCR2820670606%3E3.0.CO%3B2-I

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

21 January 2018

2

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

8 December 2022

3

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

8 December 2022

4

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer

8 December 2022

5

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Meeting Highlights: Adjuvant Therapy for Breast Cancer

8 December 2022

6

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Adjuvant therapy in node-negative breast cancer. A panel discussion

8 December 2022

7

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Proceedings of the American Association for Cancer Research

8 December 2022

8

30

253

Rosner

1989

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Node-negative minimal invasive breast cancer patients are not candidates for routine systemic adjuvant therapy

8 December 2022

9

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

8 December 2022

Breast carcinoma in situ

10

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons

8 December 2022

14

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Treatment of intraductal carcinoma with limited surgery: long-term follow-up

8 December 2022

16

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Vexed surgeons, perplexed patients, and breast cancers which may not be cancer

8 December 2022

17

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment

8 December 2022

18

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

An improved technique for the study of lymph nodes in surgical specimens

8 December 2022

19

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Standardized management of breast specimens recommended by Pathology Working Group, Breast Cancer Task Force

8 December 2022

20

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

8 December 2022

22

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

The Guildford Breast Screening Project: 6-year assessment

8 December 2022

23

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Heterogeneity of intraductal carcinoma of the breast

8 December 2022

24

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project

8 December 2022

25

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence

8 December 2022

26

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS).

8 December 2022

28

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation

8 December 2022

29

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy

8 December 2022

30

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy

8 December 2022

31

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast.

8 December 2022

32

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy

8 December 2022

33

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

Ductal carcinoma in situ (intraductal carcinoma) of the breast

8 December 2022

34

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

European Journal of Surgical Oncology

8 December 2022

35

15

328

Howard

1989

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

8 December 2022

Journal de radiologie

36

11

691

Rosner

1964

1 reference

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19910315)67:6%3C1498::AID-CNCR2820670606%3E3.0.CO;2-I

8 December 2022

Identifiers

10.1002/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I

1 reference

27 November 2017

1 reference